Alcon(US:ALC)2025-02-26 12:42Financial Performance - Q4 2024 sales reached $2.5 billion, a 6% increase year-over-year on a reported and constant currency basis[15] - Q4 2024 operating margin was 15.9%, up 700 basis points year-over-year[15] - Q4 2024 core operating margin was 20.1%, up 120 basis points year-over-year[15] - Q4 2024 diluted EPS was $0.57, down 34% year-over-year[15] - Q4 2024 core diluted EPS was $0.72, up 3% year-over-year[15] - FY24 free cash flow was $1.6 billion, compared to $0.7 billion in FY23[15] - FY24 sales reached $9.8 billion, a 5% increase year-over-year[20,35] - FY24 diluted EPS was $2.05, a 5% increase year-over-year[35] - FY24 core diluted EPS was $3.05, a 16% increase year-over-year on a constant currency basis[49] Segment Performance - Vision Care sales were $4.3 billion, representing 44% of FY24 sales[21] - Surgical sales were $5.5 billion, representing 56% of FY24 sales[21] FY 2025 Outlook - The company projects net sales of $10.2 to $10.4 billion, representing a 6% to 8% increase on a constant currency basis[63] - The company projects a core operating margin of 21% to 22%[63] - The company projects a core diluted EPS of $3.15 to $3.25, representing an 8% to 11% increase on a constant currency basis[63]